Want to see IT:EUK full AI Analyst Report?
EUK Stock Chart & Stats
€0.72
-€0.02(-2.41%)
At close: 4:00 PM EST
€0.72
-€0.02(-2.41%)
Day’s Range― - ―
52-Week Range€0.45 - €0.81
Previous CloseN/A
Volume1.70K
Average Volume (3M)4.68K
Market Cap
€11.48M
Enterprise Value€142.65M
Total Cash (Recent Filing)€416.00K
Total Debt (Recent Filing)€128.29M
Price to Earnings (P/E)―
Beta0.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,741,629
10 Day Avg. Volume3,064
30 Day Avg. Volume4,678
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.55
Price to Sales (P/S)0.31
P/FCF Ratio36.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operating Margin ResilienceEukedos shows relatively steady operating and EBITDA margins across 2021–2025, indicating an ability to cover core operating costs and absorb revenue fluctuations. Durable margin strength in a service business suggests structural cost control and operational leverage that support medium-term cash generation and service continuity.
Consistent Operating Cash FlowConsistent positive operating cash flow (roughly €5–10M annually) provides a steady internal source to fund working capital and routine capex. That cash generation cushions liquidity needs despite accounting losses, supports ongoing service delivery, and gives management a basis for gradual deleveraging or targeted reinvestment over the coming months.
Healthcare Services Network ModelEukedos operates a facility- and network-based healthcare services model, which benefits from structural demand, recurring care contracts, and regulatory barriers to entry. Facility-based delivery tends to generate predictable utilization and higher switching costs, supporting medium-term revenue visibility compared with transactional service models.
Bears Say
Very High LeverageLeverage at roughly 3.3x–4.4x and a material debt increase in 2025 materially constrain financial flexibility. High debt amplifies refinancing and interest-rate risk, limits capacity for strategic investment, and raises the likelihood of covenant pressure; deleveraging will be required to restore durable balance-sheet resilience.
Return To Net LossesThe shift to net losses in 2024–2025 erodes retained earnings and equity cushion, reducing capacity to self-fund growth or absorb shocks. Even with steady operating margins, non-operating costs or financing burdens are depressing bottom-line profitability, creating a structural profit recovery requirement to stabilize capital ratios and investor confidence.
Volatile Free Cash FlowFree cash flow swings—from strongly negative in 2024 to marginally positive in 2025—signal unreliable conversion of EBITDA into distributable cash. This volatility complicates debt repayment plans and capital investment timing, making it harder to execute a consistent deleveraging strategy or fund expansion without external financing.
Eukedos S.p.A. News
EUK FAQ
What was Eukedos S.p.A.’s price range in the past 12 months?
Eukedos S.p.A. lowest stock price was €0.45 and its highest was €0.81 in the past 12 months.
What is Eukedos S.p.A.’s market cap?
Eukedos S.p.A.’s market cap is €11.48M.
When is Eukedos S.p.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eukedos S.p.A.’s earnings last quarter?
Currently, no data Available
Is Eukedos S.p.A. overvalued?
According to Wall Street analysts Eukedos S.p.A.’s price is currently Overvalued.
Does Eukedos S.p.A. pay dividends?
Eukedos S.p.A. pays a Notavailable dividend of €0.044 which represents an annual dividend yield of N/A. See more information on Eukedos S.p.A. dividends here
What is Eukedos S.p.A.’s EPS estimate?
Eukedos S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eukedos S.p.A. have?
Eukedos S.p.A. has 22,741,629 shares outstanding.
What happened to Eukedos S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eukedos S.p.A.?
Currently, no hedge funds are holding shares in IT:EUK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eukedos S.p.A.
EuKedos S.p.A. operates in Italy, offering a range of managed and long-term care provisions. The company specializes in delivering residential social support for older adults, catering to both independent individuals and those needing extensive assistance. With 1,345 beds, it oversees healthcare and residential care facilities throughout northern and central Italy, notably in regions such as Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is headquartered in Florence, Italy.
Technical Analysis
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Svas Biosana S.p.A.
―
I.M.D. International Medical Devices S.P.A.
―
Piu Medical S.P.A.
―